Registration country:United States
Initially, Pharmion concentrated its efforts on licensing products in the areas of hematology, oncology and supportive care.
Selected investmentsDisplaying 1 - 1 of 1
|Cabrellis Pharmaceuticals Corp||Development of important therapies for the treatment of cancer||United States||2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products||USD 59,000,000 Acquisition||15 Nov 2006|
View portfolio analytics.
PSEPS ID: 107779